+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fondaparinux"

From
Fondaparinux - Global Strategic Business Report - Product Thumbnail Image

Fondaparinux - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Fondaparinux Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Fondaparinux Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Fondaparinux is a synthetic anticoagulant drug used to prevent and treat thromboembolic disorders, such as deep vein thrombosis and pulmonary embolism. It is a member of the class of drugs known as pentasaccharides, and is used in the treatment of cardiovascular diseases. Fondaparinux is administered by subcutaneous injection and is available in both generic and branded forms. It is used in combination with other anticoagulants, such as warfarin, to reduce the risk of stroke and other cardiovascular events. Fondaparinux is a widely used drug in the cardiovascular market, and is used to treat a variety of conditions, including atrial fibrillation, coronary artery disease, and peripheral artery disease. It is also used to prevent and treat venous thromboembolism, a condition in which blood clots form in the veins. Fondaparinux is marketed by several pharmaceutical companies, including Sanofi, Bristol-Myers Squibb, and Pfizer. It is also available in generic form from several generic drug manufacturers. Show Less Read more